Jun 21, 2024, 13:06 | Career

Yardena Samuels: An absolute honor to be elected as the next EACR president

Yardena Samuels, Full Professor at Weizmann Institute of Science, posted on LinkedIn: "It is an…

Jun 21, 2024, 02:08 | Insight

New Paper Alert! AtezoTRIBE Study

AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…

Jun 20, 2024, 16:06 | Blog

Oncology community on Juneteenth

Juneteenth, also known as Freedom Day or Emancipation Day, commemorates the emancipation of enslaved African…

Jun 20, 2024, 14:42 | Blog

V. Craig Jordan changed the lives of generations of women faced with a breast cancer - AACR

American Association for Cancer Research (AACR) shared on LinkedIn: “We are saddened by the loss…

Jun 20, 2024, 13:54 | Blog

NCI Center for Global Health - 3rd re-designation of the WHO Collaborating Center for Global Cancer Control

NCI Center for Global Health shared a post on X: "Today we welcomed colleagues from WHO…

Jun 19, 2024, 03:17 | Blog

Penilla Gunther: 'Rethinking healthcare' that is not easy, but worth a try!

Penilla Gunther, Member of the EU Cancer Mission Board at European Commission, shared a post by LinkedIn: …

Jun 19, 2024, 02:11 | Blog

Vincent Rajkumar: International Myeloma Foundation bringing together leaders from around the world

Vincent Rajkumar shared on X: . "The International Myeloma Working Group…

Jun 17, 2024, 15:06 | Dialogues

Oncodaily Dialogues #9 István Peták/ Hosted by Roupen Odabashian

In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…

Jun 17, 2024, 12:11 | Cancer Types

Stomach Cancer: Symptoms and Causes, Types, Diagnosis and Treatment

Stomach cancer, commonly referred to as gastric cancer, is a malignant condition originating from the…

Jun 16, 2024, 14:10 | Insight

Naveen Pemmaraju: TRANSFORM-1 results randomized Phase 3 clinical trial at EHA24

Naveen Pemmaraju shared on X: "Honored to present at EHA24 today the TRANSFORM-1 results from…

Jun 16, 2024, 02:34 | Blog

Richard Sullivan: Lessons for building future pandemic resilience into global cancer services and systems

Richard Sullivan shared a post on LinkedIn: "Building resilient health services and systems has been…

Jun 14, 2024, 01:23 | Insight

New Paper Alert! Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab

Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab Authors: Andrea J. Bullock,…

Jun 12, 2024, 15:37 | Societies

Giuseppe Curigliano has been appointed as the President Elect of ESMO

The European Society for Medical Oncology (ESMO) has announced the results of its presidential election.…

Jun 8, 2024, 06:59 | Blog

Results of the NICHE-2 trial show it to be highly effective in a subset of patients with colon cancer - The Netherlands Cancer Institute

The Netherlands Cancer Institute shared on Linkedin: “More succes for neoadjuvant immunotherapy: results of the…

Jun 6, 2024, 00:09 | Dialogues

Beyond The Cancer Diagnosis: Dialogue with Camille Moses, Hosted By Adrian Pogacian

In this episode of ‘Beyond the Cancer Diagnosis’, Camille Moses shares her personal experience during…

Jun 3, 2024, 11:06 | Blog

Calling All Cancer Survivors

OncoDaily is excited to announce the production of an empowering documentary highlighting the inspiring stories…

Jun 2, 2024, 12:03 | Blog

Drew Moghanaki: A look back at arguably the most important phase III RCT ever completed in the history of oncology

Drew Moghanaki shared on X: "Here is a look back at arguably the most important…

May 28, 2024, 08:14 | Dialogues

OncoDaily Talks: Dialogue with Gevorg Tamamyan, hosted by Neil Ranasinghe

OncoDaily Talks gathers people worldwide to discuss challenges in cancer care. We share creative solutions…

May 27, 2024, 11:56 | Positive

Pashtoon Kasi: Nice birthday present! Keeping this one close to my heart

Pashtoon Kasi shared a post by OncoDaily on LinkedIn: “Oh wow! Nice birthday present! Keeping this…

May 27, 2024, 09:13 | Insight

Vincent Rajkumar: My view on what the word Cure should mean in myeloma

Vincent Rajkumar shared a post on X: “At COMy Congress I laid out my view…

May 26, 2024, 14:54 | Dialogues

Oncothon: Pediatric oncology with Maria Babak, Jemma Arakelyan

Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…

May 26, 2024, 06:54 | Positive

Yvonne Award Winners 2024 by OncoDaily

We are excited to announce the esteemed winners of the Yvonne Award 2024 by OncoDaily, designed…

May 25, 2024, 07:14 | Dialogues

Global Ped Hem Onc Chat with Nita Radhakrishnan #2 - Neil Ranasinghe

We’re excited to present the second episode of our series, “Global Ped HemOnc Chat with…

May 23, 2024, 14:29 | Societies

The names of the candidates running for the ESMO Presidency 2027-2028 have been announced

The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find…

May 19, 2024, 18:15 | Dialogues

OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan

Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Shushan Hovsepyan. In this episode,…

May 16, 2024, 16:51 | Insight

10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily

In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…

May 16, 2024, 14:15 | Insight

Elie G. Dib: Excited to share the results of the TAPUR study

Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital,…

May 12, 2024, 07:56 | Dialogues

OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In this episode, we…

May 12, 2024, 01:23 | Societies

Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20

Cedars-Sinai Co-Chairs Special Conference in Cancer Research Covering Transformational Developments in Treatment In partnership with…

May 11, 2024, 13:18 | Career

Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!

European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "We're thrilled to announce the…

May 7, 2024, 16:05 | Insight

Neuroendocrine tumors - newly updated AJCC guidelines

Newly updated guidelines on neuroendocrine tumors developed by an expert at Sylvester Comprehensive Cancer Center…

May 6, 2024, 11:07 | Dialogues

5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari

Welcome to the world of sarcoma with the fifth episode of '5 Min Sarcoma Talk'…

May 4, 2024, 10:53 | Dialogues

OncoInfluencers: Dialogue with Tony Mok, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In this episode, we…

May 3, 2024, 14:50 | Insight

New Paper Alert! Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma

Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma Authors: Matthew D. Robinson, Roseanna Wheatley, Lucy Foster,…

May 3, 2024, 05:06 | Opinion

Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment

Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X: "On Accelerated Approval…

May 2, 2024, 12:13 | Insight

New Paper Alert! BRAF Isoforms and Resistance to MAPK Inhibitors in Melanoma

BRAF Isoforms and Resistance to MAPK Inhibitors in Melanoma Authors: Francisco Aya, Pablo Lanuza-Gracia, Abel…

May 2, 2024, 02:53 | Drugs

FDA approves lutetium Lu 177 dotatate for pediatric patients 12 years and older with GEP-NETS

FDA Approves the First Radioactive Drug for Pediatric Neuroendocrine Tumors the U.S. Food and Drug…

May 1, 2024, 11:22 | Blog

Michelle Mitchell: His Majesty is Cancer Research UK's new Patron

Michelle Mitchell shared a post on LinkedIn: "It was wonderful to meet His Majesty The…

Apr 30, 2024, 16:25 | Dialogues

The Comfort Corner #2: Dialogue with Prof. Florian Scotté, hosted by Martin Harutyunyan

"The Comfort Corner" is a palliative care series that brings together medical professionals with the…

Apr 30, 2024, 11:17 | Insight

New Paper Alert! Targeting NECTIN4. Predicting Response to Enfortumab Vedotin in Metastatic Urothelial Cancer

Targeting NECTIN4. Predicting Response to Enfortumab Vedotin in Metastatic Urothelial Cancer Authors: Niklas Klümper, MD,…

Apr 30, 2024, 07:06 | Insight

Myeloma Paper of the Day, April 29th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…

Apr 28, 2024, 16:18 | Societies

OncoDaily Leukemia Conference: Day 2

"The best specialists in the field of hematology and numerous interesting and informative reports. The…

Apr 27, 2024, 10:58 | Blog

The King will soon return to public duties after recovering from cancer treatment

The Royal Family shared the latest news about King Charles' recovery on their X page:…

Apr 27, 2024, 07:08 | Blog

Oncologist Near Me - Eric Small: Prominent Prostate Cancer Specialist

Oncologist Near Me: Eric Small Special initiative by OncoDaily Welcome to OncoDaily's special section "Oncologist…

Apr 26, 2024, 17:42 | Insight

New Paper Alert! The Role of MicroRNAs in Hepatocellular Carcinoma: Understanding Tumor Microenvironment and Drug Resistance Mechanisms

The Role of MicroRNAs in Hepatocellular Carcinoma: Understanding Tumor Microenvironment and Drug Resistance Mechanisms Authors:…

Apr 25, 2024, 19:48 | Insight

New Paper Alert! The INNOVATED Cohort: The Role of Immune Checkpoint Blockers in Solid Organ Transplant Recipients with Cancer

The INNOVATED Cohort: The Role of Immune Checkpoint Blockers in Solid Organ Transplant Recipients with…

Apr 25, 2024, 14:18 | Career

Gevorg Tamamyan: It is an extreme honor being elected as the President-Elect of SIOP Asia

Gevorg Tamamyan shared on LinkedIn: "It is an extreme honor being elected as the President-Elect of…

Apr 25, 2024, 00:51 | Insight

New Paper Alert! Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma

Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma Authors: T. Powles,…

Apr 24, 2024, 17:24 | Blog

U.S. FDA approved the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma - Day One Biopharmaceuticals

Day One Biopharmaceuticals shared a post on LinkedIn: "Breaking News: Today, we are thrilled to share…

Apr 24, 2024, 12:52 | Blog

Monica Bertagnolli: NIH will increase annual pay levels for predoctoral and postdoctoral scholars who are recipients of the Ruth L. Kirschstein National Research Service Awards (NRSA)

Apr 24, 2024, 09:13 | Drugs

FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer

FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…

Apr 23, 2024, 18:57 | Insight

New Paper Alert! Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of the Literature

Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of…

Apr 22, 2024, 19:23 | Insight

New Paper Alert! A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners Foundation

A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners…

Apr 22, 2024, 11:59 | Positive

Yvonne Award 2024 by OncoDaily

The Yvonne Award by OncoDaily, symbolizing the strength and longevity of the yew tree, honors…

Apr 22, 2024, 11:11 | Insight

New Paper Alert! Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy

Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated…

Apr 21, 2024, 08:54 | Insight

Rana McKay wins the 2024 Christopher G. Wood Rising Star Award at IKCS Europe

Rana McKay won the 2024 Christopher G. Wood Rising Star Award at IKCS Europe, which…

Apr 21, 2024, 08:05 | Insight

New Paper Alert! Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer

Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer…

Apr 21, 2024, 06:16 | Dialogues

Oncodaily Dialogues #8 Mikkael Sekeres/ Hosted by Roupen Odabashian

In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…

Apr 20, 2024, 06:18 | Insight

New Paper Alert! Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer

Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer Authors: David Planchard, Rachel E. Sanborn,…

Apr 19, 2024, 16:30 | Insight

New Paper Alert! Outcomes of high-risk individuals undergoing pancreatic cancer surveillance

Effective Surveillance Strategies for High-Risk Pancreatic Cancer Individuals Authors: Aleksander M. Bogdanski, Jeanin E. van…

Apr 18, 2024, 16:36 | Insight

New Paper Alert! Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy

Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy Authors: Pierre-Louis Cariou,…

Apr 18, 2024, 11:57 | Insight

New Paper Alert! The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based on Microsatellite Instability Status

The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based…

Apr 17, 2024, 13:11 | Insight

New Paper Alert! Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal Cancer: A Real-World Analysis

New Paper Alert: Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal…

Apr 13, 2024, 11:51 | Dialogues

OncoDaily Walk and Talk with Dinesh Pendharkar, Hosted by Tatev Margaryan

Welcome back to Walk and Talk on OncoDaily! Our guest for today is Dinesh Pendharkar.…

Apr 13, 2024, 03:43 | Blog

FDA ODAC voted 12-0. Historic victory in multiple myeloma

On April 12, 2024, FDA ODAC voted 12-0 in favor of using minimal residual disease…

Apr 12, 2024, 03:19 | Dialogues

OncoInfluencers: Dialogue with Pasi Jänne, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In…

Apr 8, 2024, 22:37 | Insight

Key Message Highlights from Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous…

Apr 6, 2024, 16:25 | Insight

New Article Alert! FOLFIRI plus durvalumab with or without tremelimumab in advanced gastric or GEJ adenocarcinoma

FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal…

Apr 6, 2024, 16:19 | Insight

Nivolumab with chemotherapy to use before surgery in patients with pancreatic cancer - UCLA Health Jonsson Comprehensive Cancer Center

A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for…

Mar 31, 2024, 11:21 | Positive

Gevorg Tamamyan: Get your best dresses and prepare your luxury shoes for The Biggest and Amazing Party of the Year

Gevorg Tamamyan, the Editor-in-chief of OncoDaily, shared on X/Twitter: "It is an extreme honor and pleasure…

Mar 30, 2024, 11:05 | Dialogues

The Comfort Corner #1: Dialogue with Matti Aapro, hosted by Martin Harutyunyan

Welcome to "The Comfort Corner" - a palliative care series that brings together medical professionals…

Mar 28, 2024, 19:11 | Dialogues

OncoInfluencers: Dialogue with Douglas Flora, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In…

Mar 27, 2024, 11:45 | Societies

Rob Pieters is the newly elected President of International Society of Paediatric Oncology – SIOP

“If cure rates for ALL can go from 0% to 85% in 40 years we…

Mar 26, 2024, 14:54 | Dialogues

Cancer and Crisis Talks with Jemma Arakelyan #3 - Dr. Nazik Hammad

We are thrilled to unveil the next captivating episode of our enlightening series, "Cancer and…

Mar 24, 2024, 02:12 | Opinion

OncoDaily is happy to become the official partner of the International Society of Paediatric Oncology (SIOP)

It is with great honor and immense pleasure that we announce the official partnership between…

Mar 23, 2024, 15:29 | Dialogues

OncoDaily Dialogues #7: Aparna Parikh / Hosted by Roupen Odabashian

In our ongoing series called “OncoDaily Dialogues,”we consistently feature prominent individuals in the field of…

Mar 22, 2024, 16:24 | Positive

Top 100 Xfluencers in Colorectal Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

As March, Colorectal Cancer Awareness Month, draws to its end, we're excited to announce our…

Mar 22, 2024, 15:57 | Dialogues

OncoInfluencers: Dialogue with Lillian L. Siu, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In…

Mar 22, 2024, 02:24 | Positive

Lillian Siu Honored with the 2024 ASCO David Karnofsky Memorial Award

The American Society of Clinical Oncology (ASCO) has announced Dr. Lillian L. Siu, MD, FRCPC,…

Mar 20, 2024, 16:53 | Insight

Vincent Rajkumar: ODAC votes 11-0 to recommend approval of Cilta-Cel in patients with relapsed/refractory multiple myeloma in earlier stages

Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X/Twitter: "Breaking: ODAC votes…

Mar 16, 2024, 10:29 | Dialogues

OncoDaily Dialogues #6 – Navneet Singh / Hosted by Roupen Odabashian

In our ongoing series called "OncoDaily Dialogues," we consistently feature prominent individuals in the field…

Mar 15, 2024, 10:13 | Blog

AACR members have elected Lillian L. Siu as their 2024-2025 President-Elect

AACR shared a post on X: "AACR members have elected AACR Fellows Lillian L. Siu, MD,…

Mar 14, 2024, 18:42 | Dialogues

5 min Sarcoma Talk with Shushan Hovsepyan and Leo Kager

Welcome to the world of sarcoma with the first episode of '5 Min Sarcoma Talk'…

Mar 11, 2024, 20:55 | Stories

Tracey O'Brien: This international women's day threw me the best curveball yet, and it came from none other than my 14-year-old son

Tracey O'Brien, NSW Chief Cancer Officer, posted on LinkedIn: "This international women's day threw me the…

Mar 11, 2024, 03:24 | Career

Amer Zeidan was appointed as the inaugural Chief of the Division of Hematologic Malignancies at Yale Cancer Center

Yale Cancer Center shared on LinkedIn: "We are pleased to announce that Amer Zeidan was…

Mar 10, 2024, 21:03 | Blog

Vivek Subbiah: Research should be standard-of-care and standard-of-care should be research

Vivek Subbiah recently posted on LinkedIn: "Yes! “Research should be standard-of-care and standard-of-care should be research”!!!…

Mar 9, 2024, 19:24 | Blog

11 posts not to miss from International Women's Day 2024

International Women's Day is celebrated annually on March 8th. Below are featured some of the…

Mar 9, 2024, 18:49 | Societies

Global Summit on War and Cancer 2023: Julie Gralow's speech on the role of professional societies in supporting cancer care in conflict zones

The 1st Global Summit on War and Cancer took place on 14 - 16 December…

Mar 4, 2024, 01:54 | Dialogues

OncoDaily Walk and Talk with Enrique Soto, Hosted by Tatev Margaryan

Welcome back to Walk & Talk on OncoDaily! Our guest for today is Dr. Enrique…

Mar 2, 2024, 12:46 | Dialogues

OncoInfluencers: Dialogue with Julie Gralow, hosted by Gevorg Tamamyan

Join us for an exciting episode of “OncoInfluencers,” with our host Dr. Gevorg Tamamyan. In…

Mar 1, 2024, 18:29 | Insight

Tedros Adhanom Ghebreyesus: I recently saw a report of 40 people who needed dialysis dying in one state in Sudan, and this situation is not unique to Sudan.

Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, shared on X/Twitter: "Cancer, diabetes, heart…

Feb 28, 2024, 18:16 | Blog

Rebecca Shatsky: We need to do more to debunk this growing threat of total disinformation

Rebecca Shatsky shared a post on X/Twitter: "I had a patient recently with advanced stage…

Feb 26, 2024, 11:06 | Stories

Daniella T.: Even if we’re apart… I’ll always be with you

Daniella T. shared on LinkedIn: "If you’re reading this then it means I have died…

Feb 22, 2024, 18:13 | Blog

Jill Biden: I am excited to share the first major deliverable from our White House Initiative on Women’s Health Research

Jill Biden recently shared on X/Twitter: "Today, I am excited to share the first major…

Feb 19, 2024, 04:12 | Dialogues

OncoDaily Walk and Talk with Maite Gorostegui, Hosted by Tatev Margaryan

Welcome back to Walk & Talk on OncoDaily! Our guest for today is Dr. Maite…

Feb 14, 2024, 14:59 | Blog

Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL

Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…

Feb 11, 2024, 07:31 | Insight

Belén Garijo: I´m grateful to everyone across the scientific community who think and act like Einstein

Belén Garijo, Chair of the Executive Board and CEO of Merck, shared on LinkedIn: "There…

Feb 5, 2024, 03:55 | Dialogues

OncoInfluencers: Dialogue with Nagashree Seetharamu, hosted by Gevorg Tamamyan

Join us for an exciting episode of “OncoInfluencers,” with our host Dr. Gevorg Tamamyan. In…

Feb 5, 2024, 02:47 | Opinion

Piotr J. Wysocki: The Armenian Oncology Congress is an example of how oncology is developing extremely dynamically in this small but very ambitious country

Piotr J. Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University…

Feb 4, 2024, 11:12 | Blog

Rafael Grossi: Monumental steps in ensuring quality cancer care is accessible to all, regardless of geography

Rafael Grossi, Director General at the International Atomic Energy Agency (IAEA), shared on their LinkedIn:…

Headlines

OncoDaily

Headlines